Our Research
We provide you with access to the most promising clinical trials
Because we are dedicated to academic-level care, we actively participate in breast health research by evaluating new procedures and techniques. We stay on top of the latest developments and are proactive about guiding you into clinical trials whenever it is appropriate and possible. Here are the trials we are currently involved in:
| Clinical Trial Name: | SonoCine Semi Automatic Bilateral Whole Breast Sonography and screening mammography |
| Protocol Number: | SonoCine IRB#03-032 |
| Stage/Category: | 0 |
| Trial Type: | Screening |
| Description: | This is a clinical research study to measure how useful an automated whole breast ultrasound is when combined with mammography in finding breast cancer in women who have no breast lumps or other clinical signs or symptoms of breast cancer. |
| Clinical Trial Name: | Prospective Clinical Trial of High Resolution Positron Emission Tomography with FDG |
| Protocol Number: | PEM 04-04 |
| Stage/Category: | 0 |
| Trial Type: | Diagnostic |
| Description: | This is a research study to measure how useful a diagnostic technique called Positron Emmission Mammography (referred to as PEM) is in finding and describing small areas of breast cancer when compared to current standard imaging techniques. This technique uses a device that combines the medication (2{F-18}-fluorodeoxyglucose as "FDG"), with a high resolution imaging device called a positron emission tomography (PET) scanner. |
| Clinical Trial Name: | NSABP B39 A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) For Women With Stage 0, I or II Breast Cancer |
| Protocol Number: | NSABP B39 |
| Stage/Category: | 0, I, II |
| Trial Type: | Treatment |
| Description: | The purpose of this study is to see if partial breast irradiation (PBI) is as good as or better than whole breast irradiation (WBI) in keeping cancer from coming back in the breast after removal of a lump (lumpectomy). |
| Clinical Trial Name: | A Multicenter, Prospective, Blinded-reader Study to Determine the Sensitivity and Specificity of the ComfortScan System to Detect Malignancy as an Adjunct to Mammography in Patients = 50 Years of Age (DOBI-1009) |
| Protocol Number: | DOBI-1009 |
| Stage/Category: | BIRADS 3 or 4 going to biopsy |
| Trial Type: | Breast |
| Description: | This is a screening trial of a breast imaging device, the DOBI ComfortScan. The ComfortScan uses near-infra red light to find areas of new blood vessel formation in suspected tumor areas |
Ask a Question or